Matthew VANDER HEIDEN, MD PhD

Massachussetts Institute of Technology (MIT), CAMBRIDGE, MA, US

Matthew Vander Heiden is Associate professor at the Koch Institute for Integrative Cancer Research, Department of Biology, MIT (USA), an Institute Member of the Broad Institute of Harvard and MIT, and a Instructor in Medicine at the Dana-Farber Cancer Institute / Harvard Medical School (USA).
He has received several honors and distinctions, such as the Stand Up To Cancer Innovative Research Grant Scientist (2016), the Eisen and Chang Career Development Chair, Koch Institute at MIT (2014), the AACR Gertrude B. Elion Award (2014), the Ludwig/MIT Center for Molecular Oncology Member (2013), the Howard S. and Linda B. Stern Career Development Professorship (2011-2014), the Burroughs Wellcome Fund Career Award for Medical Sciences (2009), the Mel Karmazin Fellowship, Damon Runyon Cancer Research Foundation (2006-2008), Leon O. Jacobson Basic Science Prize for the most meritorious basic science research performed by an M.D./Ph.D. student (2002), John Van Prohaska Award for outstanding potential in teaching, research and clinical medicine (2002).
Matthew Vander Heiden is present at several consulting and advisory boards on cancer research and has published 100 papers, 3 book chapters and has filed three patents. His research aims to understand the biochemical pathways used by cells meet the metabolic requirements of cell proliferation, and how regulation of these pathways contributes to cancer biology in vivo. Ultimately, he aims to translate the understanding of cancer cell metabolism into novel cancer therapies.